Sophisticated and simple
Introduction Atrial fibrillation (AF) is a leading cause of stroke, heart failure, and mortality worldwide. Beyond rhythm control, identifying which patients are most likely to…

Overview: Rethinking Anticoagulation After AF Ablation New data from the OCEAN trial suggest that stopping direct oral anticoagulants (DOACs) after a successful atrial fibrillation (AF)…

New Evidence Suggests DOACs May Be Stopped After Successful AF Ablation in Low-Risk Patients A new analysis from the OCEAN trial presents a provocative finding…

Understanding the Challenge: Platelet Reactivity After PCI Dual antiplatelet therapy (DAPT), typically aspirin plus a P2Y12 receptor antagonist, is standard care after percutaneous coronary intervention…
